Authors

Rex Chin-Wei Yung, MD

Latest:

Dr. Yung Discusses Forming a Multidisciplinary Team

Dr. Rex Yung from Sidney Kimmel Comprehensive Cancer Center Discusses Forming a Multidisciplinary Team

Reynaldo Garcia, RN, OCN

Latest:

Reynaldo Garcia on CML BCR-ABL Testing

Reynaldo Garcia From Lineberger Comprehensive Cancer Center on CML BCR-ABL Testing Recommendation

Reza Mehrazin, MD

Latest:

Dr. Mehrazin on Findings From the CARMENA Trial in Metastatic RCC

Reza Mehrazin, MD, discusses the findings of the phase III CARMENA trial in metastatic renal-cell carcinoma.

Riad Salem, MD

Latest:

Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial

Expert Riad Salem, MD, MBA, highlights key data from the phase 3 EPOCH study, which evaluated TheraSphere in patients with mCRC and liver metastases who failed first line chemotherapy.

Riad Salem, MD, Northwestern University

Riad Salem, MD, Northwestern University Feinberg School of Medicine

Latest:

Updates in Frontline Treatment of Metastatic Liver Cancer

Ricardo Gonzalez MD

Latest:

Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue Sarcomas

Neoadjuvant radiation with dendritic cell injections has the potential to be safe, effective, and immunogenic in high-grade soft tissue sarcoma and needs to be confirmed in randomized larger clinical trials.

Ricardo H. Alvarez, MD, MSc

Latest:

Dr. Alvarez on Updated Findings With Eribulin in Patients With HER2- Breast Cancer

Ricardo H. Alvarez, MD, MSc, director of Cancer Research, breast medical oncologist, Southeastern Regional Medical Center, Cancer Treatment Centers of America, discusses updated findings regarding the mechanism of action with eribulin mesylate (Halaven) and how it impacts patients with HER2-negative breast cancer.

Riccardo Lencioni, MD

Latest:

Dr Lencioni on Unmet Needs in Unresectable HCC

Riccardo Lencioni, MD, FSIR, EBIR, discusses unmet needs in unresectable hepatocellular carcinoma.

Riccardo Lencioni, MD, FSIR, EBIR, Miami Cancer Institute

Riccardo Lencioni, MD, Sylvester Comprehensive Cancer Center

Riccardo Lencioni MD, University of Miami Health System

Riccardo Lencioni, MD, University of Miami Miller School of Medicine

Richa Dawar, MD

Latest:

Dr. Dawar on Challenges With Neratinib in Metastatic HER2+ Breast Cancer

Richa Dawar, MD, discusses challenges with the use of neratinib in patients with metastatic HER2-positive breast cancer.

Richard Bryce, MBChB, MRCGP, MFPM

Latest:

Effective Management and Prevention of Neratinib-Induced Diarrhea

Safety data from clinical trials suggest that a prophylactic regimen reduces both the severity and duration of neratinib-associated diarrhea.

Richard C. Koya, MD, PhD

Latest:

Beyond CARs: New T-Cell Strategies Take Center Stage

Recent advances in the understanding of the immune system are paving the way for new and effective approaches to treating cancer.

Richard Carvajal, MD

Latest:

Dr. Carvajal Discusses the Biology of Extracutaneous Melanoma

Richard Carvajal, MD, director of Experimental Therapeutics and director of the Melanoma Service at Columbia University Medical Center, discusses the biology and distinctions of extracutaneous melanoma.

Richard D. Carvajal, MD

Richard D. Carvajal, MD, is physician-in-chief and director of medical oncology at the Northwell Health Cancer Institute, and leads all hematology and medical oncology programs across Northwell’s cancer network.

Latest:

A Close Look at Clinical Trials in Oncology and Beyond: Looking Toward the Future

In this last episode, experts underscore the importance of incorporating the patient voice into clinical trial processes.

Richard D. Hall, MD

Latest:

Dr. Hall on Combination Approaches in Advanced NSCLC

Richard D. Hall, MD, assistant professor, Hematology/Oncology, University of Virginia Health System, discusses combination approaches in advanced non–small cell lung cancer (NSCLC).

Richard E. Champlin, MD

Latest:

Dr Champ on the Consideration of Using Radiation Therapy in Breast Cancer

Colin E. Champ, MD, discusses the importance of considering the use of radiation therapy for patients with breast cancer and details ongoing research into this arena.